June 18, 2013 9:39 PM ET

Pharmaceuticals

Company Overview of Inflabloc Pharmaceuticals, Inc.

Key Executives for Inflabloc Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Willem F. O. Spiegel M.B.ANo RelationshipsActing Chief Financial Officer--
Claire A. Daugherty No RelationshipsDirector of Clinical Development--
John R. Gebhard Ph.d.No RelationshipsDirector of Research & Development--
Paul A. Litka M.d.No RelationshipsActing Medical Director63
David L. Vollmer Ph.d.No RelationshipsDirector of Analytical Development and Quality Control--

Inflabloc Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Friedli 27 RelationshipsOsiris Therapeutics, Inc.58
Peter D. Meldrum Ph.D. 67 RelationshipsMyriad Genetics Inc.65
View All Board Members

Inflabloc Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
449.6K
Bonus
491.3K
Total Short Term Compensation
624.8K
Total Value of Options
10.5M
Compensation as of Fiscal Year
Inflabloc Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Reckitt Benckiser Group plc Announces Graham Mackay Stepped Down from the Board
June 13, 2013 8:00 AM ET
Central Garden & Pet Company Announces Cessation of Gus Halas as Executive Officer
June 06, 2013 12:00 AM ET
Procter & Gamble Company Organizes Global Business Units into Industry-Based Sectors; Announces Management Changes, Effective from July 1, 2013
June 05, 2013 8:25 PM ET
Armored AutoGroup, Inc. Promotes Guy J. Andrysick to Executive Vice President and Chief Operating Officer
June 03, 2013 12:00 AM ET
Farmax India Ltd Approves Executive Changes
May 30, 2013 12:00 AM ET

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inflabloc Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.